Role of the Phagocyte in Host-Parasite Interactions XXVII. Myeloperoxidase-H(2)O(2)-Cl-Mediated Aldehyde Formation and Its Relationship to Antimicrobial Activity
Overview
Authors
Affiliations
Evidence is presented which suggests that the mechanism of action of the myeloperoxidase-H(2)O(2)-Cl(-) antimicrobial system in the phagocyte is by the formation of aldehydes. Aldehyde production resulting from myeloperoxidase-mediated decarboxylation and deamination of alanine was quantitated with 20,000-g granules from guinea pig polymorphonuclear leukocytes serving as the enzyme. Equimolar quantities of acetaldehyde and CO(2) were obtained. There was an absolute requirement for both H(2)O(2) and Cl(-) for decarboxylation by the myeloperoxidase-containing granules. The myeloperoxidase-H(2)O(2)-Cl(-) system decarboxylated both d- or l-alanine equally and had a pH optimum of 5.3. Decarboxylation of l-alanine by intact guinea pig polymorphonuclear leukocytes was increased 2.5-fold by phagocytosis. Guaiacol peroxidation by the granules was inhibited 90% in the presence of Cl(-) at acid pH. Under these conditions, decarboxylation and deamination of amino acids by myeloperoxidase were significantly stimulated, resulting in aldehyde production. Taurine, a competitive inhibitor of amino acid decarboxylation, inhibited bactericidal activity of the myeloperoxidase-H(2)O(2)-Cl(-) system but had no effect on the myeloperoxidase-H(2)O(2)-I(-) bactericidal system. Since the myeloperoxidase-H(2)O(2)-I(-) system does not participate in amino acid decarboxylation, its mechanism of antimicrobial action appears to be different from that found with Cl(-).
Evidence that endogenous formaldehyde produces immunogenic and atherogenic adduct epitopes.
Nakamura J, Shimomoto T, Collins L, Holley D, Zhang Z, Barbee J Sci Rep. 2017; 7(1):10787.
PMID: 28883613 PMC: 5589919. DOI: 10.1038/s41598-017-11289-8.
Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system.
Nauseef W Int J Hematol. 2001; 74(2):125-33.
PMID: 11594511 DOI: 10.1007/BF02981994.
Anderson M, Requena J, Crowley J, Thorpe S, Heinecke J J Clin Invest. 1999; 104(1):103-13.
PMID: 10393704 PMC: 408396. DOI: 10.1172/JCI3042.
Anderson M, Hazen S, Hsu F, Heinecke J J Clin Invest. 1997; 99(3):424-32.
PMID: 9022075 PMC: 507815. DOI: 10.1172/JCI119176.
Oxidative modification of inflammatory synovial fluid immunoglobulin G.
Jasin H Inflammation. 1993; 17(2):167-81.
PMID: 8387962 DOI: 10.1007/BF00916103.